Muthusamy V Raman, Bruno Marco J, Kozarek Richard A, Petersen Bret T, Pleskow Douglas K, Sejpal Divyesh V, Slivka Adam, Peetermans Joyce A, Rousseau Matthew J, Tirrell Gregory P, Ross Andrew S
Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
Department of Gastroenterology and Hepatology; Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands.
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2108-2117.e3. doi: 10.1016/j.cgh.2019.10.052. Epub 2019 Nov 6.
BACKGROUND & AIMS: Disposable, single-use duodenoscopes might reduce outbreaks of infections associated with endoscope reuse. We tested the feasibility, preliminary safety, and performance of a new single-use duodenoscope in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).
We conducted a case-series study of the outcomes of ERCP with a single-use duodenoscope from April through May 2019 at 6 academic medical centers. We screened consecutive patients (18 years and older) without alterations in pancreaticobiliary anatomy and enrolled 73 patients into the study. Seven expert endoscopists performed roll-in maneuvers (duodenoscope navigation and visualization of duodenal papilla only) in 13 patients and then ERCPs in the 60 other patients. Outcomes analyzed included completion of ERCP for the intended clinical indication, crossover from a single-use duodenoscope to a reusable duodenoscope, endoscopist performance ratings of the device, and serious adverse events (assessed at 72 hours and 7 days).
Thirteen (100%) roll-in maneuver cases were completed using the single-use duodenoscope. ERCPs were of American Society for Gastrointestinal Endoscopy procedural complexity grade 1 (least complex; 7 patients [11.7%]), grade 2 (26 patients [43.3%]), grade 3 (26 patients [43.3%]), and grade 4 (most complex; 1 patient [1.7%]). Fifty-eight ERCPs (96.7%) were completed using the single-use duodenoscope only and 2 ERCPs (3.3%) were completed using the single-use duodenoscope followed by crossover to a reusable duodenoscope. Median overall satisfaction was 9 out of 10. Three patients developed post-ERCP pancreatitis, 1 patient had post-sphincterotomy bleeding, and 1 patient had worsening of a preexisting infection and required rehospitalization.
In a case-series study, we found that expert endoscopists can complete ERCPs of a wide range of complexity using a single-use duodenoscope for nearly all cases. This alternative might decrease ERCP-related risk of infection. Clinicaltrials.gov no: NCT03701958.
一次性使用的十二指肠镜可能会减少与内镜重复使用相关的感染暴发。我们测试了一种新型一次性十二指肠镜在接受内镜逆行胰胆管造影术(ERCP)患者中的可行性、初步安全性及性能。
我们于2019年4月至5月在6家学术医疗中心对使用一次性十二指肠镜进行ERCP的结果开展了一项病例系列研究。我们筛选了胰胆管解剖结构无改变的连续患者(年龄18岁及以上),并将73例患者纳入研究。7名专家内镜医师对13例患者进行了插入操作(仅十二指肠镜导航和十二指肠乳头可视化),然后对其他60例患者进行了ERCP。分析的结果包括是否完成了针对预期临床指征的ERCP、从一次性十二指肠镜转换为可重复使用十二指肠镜的情况、内镜医师对该设备的性能评级以及严重不良事件(在72小时和7天时评估)。
13例(100%)插入操作病例使用一次性十二指肠镜完成。ERCP的美国胃肠内镜学会手术复杂程度分级为1级(最不复杂;7例患者[11.7%])、2级(26例患者[43.3%])、3级(26例患者[43.3%])和4级(最复杂;1例患者[1.7%])。58例ERCP(96.7%)仅使用一次性十二指肠镜完成,2例ERCP(3.3%)使用一次性十二指肠镜完成后转换为可重复使用十二指肠镜。总体满意度中位数为10分中的9分。3例患者发生了ERCP后胰腺炎,1例患者出现括约肌切开术后出血,1例患者原有感染加重,需要再次住院治疗。
在一项病例系列研究中,我们发现专家内镜医师几乎可以使用一次性十二指肠镜完成各种复杂程度的ERCP。这种替代方法可能会降低ERCP相关的感染风险。Clinicaltrials.gov编号:NCT03701958。